Masimo wins FDA nod for noninvasive sensors with the Root patient monitoring platform

Masimo (NSDQ:MASI) said today it won FDA 510(k) clearance for noninvasive blood pressure and temperature monitoring through its Root platform.

The Root platform features integrated non-invasive blood pressure monitoring from SunTech Medical, which allows for spot checks, automatic interval checks or stat interval checks, and a temperature module from Welch Allyn  designed for adult and pediatric patients.

“We are excited to bring this addition to the U.S. market. We designed Root to do for patient monitoring what PCs did for computing. By creating a platform which allows 3rd-party measurement expansion, with an intuitive user interface and network connectivity, we hope to speed up innovation while reducing the cost of monitoring, as well as potentially improving patient care and patient safety,” CEO Joe Kiani said in a press release.

The system allows for the automatic charting of vital signs directly from the Root platform which can send data directly to patient’s electronic medical records through Masimo’s Patient SafetyNet, the company said.

The system can also integrate measurements from Masimo’s Radical-7 handheld designed for SET measure-through motion and low perfusion pulse oximetry, continuous hemoglobin, PVI, or data from the Radius-7 patient worn monitor, the company said.

The post Masimo wins FDA nod for noninvasive sensors with the Root patient monitoring platform appeared first on MassDevice.

from MassDevice http://ift.tt/1oKtLWf